Back
Summit Therapeutics Quote, Financials, Valuation and Earnings
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
SMMT
Summit Therapeutics
Last Price:
19.72
Seasonality Move:
33.87%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Summit Therapeutics Price Quote
$19.72
+0.80 (+4.23%)
(Updated: October 8, 2024 at 6:55 PM ET)
Summit Therapeutics Key Stats
Sell
44
Summit Therapeutics (SMMT)
is a Sell
Day range:
$18.71 - $20.18
52-week range:
$1.64 - $33.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13,897.66
P/B ratio:
71.28%
Volume:
2.4M
Avg. volume:
8.4M
1-year change:
975%
Market cap:
$13.9B
Revenue:
$0
EPS:
$-0.19
How Much Does Summit Therapeutics Make?
Data Unavailable
Is Summit Therapeutics Growing As A Company?
Data Unavailable
Summit Therapeutics Stock Price Performance
-
Did Summit Therapeutics Stock Go Up Last Month?
Summit Therapeutics share price went up by 54.2% last month -
Did SMMT's Share Price Rise Over The Last Year?
SMMT share price rose by 975% over the past 1 year
What Is Summit Therapeutics 52-Week High & Low?
-
What Is Summit Therapeutics’s 52-Week High Share Price?
Summit Therapeutics has traded as high as $33.89 over the past 52 weeks -
What Is Summit Therapeutics’s 52-Week Low Share Price?
Summit Therapeutics has traded as low as $1.64 over the past 52 weeks
Summit Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Summit Therapeutics?
-
How Much Debt Does Summit Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Summit Therapeutics Have?
Cash and short term investments quarterly total is $325.5M -
What Is Summit Therapeutics’s Book Value Per Share?
Book value per share is 0.27
Is Summit Therapeutics Cash Flow Positive?
-
What Is SMMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$97.5M -
What Is Summit Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $207.2M -
What Is Summit Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$123.1M
Summit Therapeutics Return On Invested Capital
Data Unavailable
Summit Therapeutics Earnings Date & Stock Price
-
What Is Summit Therapeutics's Stock Price Today?
A single share of SMMT can be purchased today for 18.92 -
What Is Summit Therapeutics’s Stock Symbol?
Summit Therapeutics trades on the nasdaq under the ticker symbol: SMMT -
When Is Summit Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Summit Therapeutics is scheduled on November 7, 2024 -
When Is SMMT's next ex-dividend date?
Summit Therapeutics's next ex-dividend date is October 9, 2024 -
How To Buy Summit Therapeutics Stock?
You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Summit Therapeutics Competitors
-
Who Are Summit Therapeutics's Competitors?
Below is a list of companies who compete with Summit Therapeutics or are related in some way:
Summit Therapeutics Dividend Yield
-
What Is SMMT Dividend Yield?
Summit Therapeutics’s dividend yield currently is 0% -
What Is Summit Therapeutics’s Payout Ratio?
Summit Therapeutics’s payout ratio is 0% -
When Did Summit Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 9, 2024 -
What Is Summit Therapeutics’s Dividend Per Share?
Summit Therapeutics pays a dividend of $0.00 per share
Summit Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -44.76% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 35.88 |
| Upside from Last Price: | 89.65% |